Table 1.
Characteristic | Population (N = 159) | Positive tests (N = 144) |
---|---|---|
n (%) | n (%) | |
Age group | ||
60–69 | 131 (82.4) | 116 (80.5) |
70–79 | 23 (14.5) | 23 (16.0) |
80+ | 5 (3.1) | 5 (3.5) |
Race/ethnicity | ||
White | 31 (19.5) | 30 (20.8) |
Black | 17 (10.7) | 17 (11.8) |
Mixed race | 100 (62.9) | 87 (60.4) |
Asian | 3 (1.9) | 2 (1.4) |
Indigenous | 3 (1.9) | 3 (2.1) |
Not answered | 5 (3.1) | 5 (3.5) |
Underlying health conditions | ||
Hypertension | 86 (54.1) | 79 (54.9) |
Diabetes | 28 (17.6) | 28 (19.4) |
Psychiatry disorders | 22 (13.8) | 20 (13.9) |
Gastritis | 6 (3.8) | 6 (4.2) |
Asthma | 4 (2.5) | 4 (2.8) |
Hepatitis C | 2 (1.3) | 2 (1.4) |
HIV | 1 (0.6) | 1 (0.7) |
Presence of symptomsa | N = 127 | |
Fever | 37 (23.2) | 35 (27.6) |
Fatigue | 34 (21.4) | 34 (26.8) |
Headache | 29 (18.2) | 26 (20.5) |
Myalgia | 27 (17.0) | 27 (21.3) |
Chills | 26 (16.3) | 25 (19.7) |
Changes in taste or smell | 25 (15.7) | 24 (18.9) |
Cough | 21 (13.2) | 19 (15.0) |
Coryza | 19 (11.9) | 16 (12.6) |
Diarrhoea | 14 (8.8) | 14 (11.0) |
Dyspnoea | 12 (7.5) | 11 (8.7) |
Abdominal pain | 11 (6.9) | 11 (8.7) |
Sore throat | 10 (6.3) | 8 (6.3) |
Nausea/vomiting | 6 (3.8) | 6 (4.7) |
Data related to the first mass testing, when 68/127 positive cases referred to having any symptoms.